Table 2.
Final linear mixed-effects model results summary (fixed effects), across all skill domainsa,b.
| Predictors | Estimates (SE) | t test (df) | P value | ||||
| Fixed effects | |||||||
|
|
Intercept | 1.36×10−1 (1.18×10−2) | 12.27 (2.51×101) | <.001c | |||
|
|
Week | 9.28×10−3 (1.22×10−3) | 7.62 (1.73×101) | <.001 | |||
|
|
Dosage group (2 days per week) | 1.15×10−3 (2.22×10−3) | 0.52 (1.34×104) | .60 | |||
|
|
Dosage group (3 days per week) | 8.00×10−3 (2.54×10−3) | 3.16 (8.21×103) | .002 | |||
|
|
Dosage group (4 days per week) | 8.30×10−3 (2.85×10−3) | 2.91 (7.91×103) | .004 | |||
|
|
Dosage group (≥5 days per week) | 1.13×10−2 (2.86×10−3) | 3.95 (5.09×103) | <.001 | |||
|
|
Total hours | 1.13×10−4 (3.15×10−5) | 3.58 (6.05×104) | <.001 | |||
|
|
Domain score baseline | 6.62×10−1 (2.55×10−3) | 259.42 (1.04×105) | <.001 | |||
|
|
Age (years) | −1.54×10−4 (8.96×10−5) | −1.72 (1.79×103) | .09 | |||
|
|
Sex (male) | −1.39×10−4 (2.43×10−3) | −0.06 (1.78×103) | .95 | |||
|
|
Sex (not specified) | 2.13×10−2 (1.66×10−2) | 1.28 (1.83×103) | .20 | |||
|
|
Chronicity (acute) | 9.93×10−3 (2.44×10−3) | −4.07 (1.75×103) | <.001 | |||
|
|
Week × dosage group (2 days per week) | 1.13×10−3 (4.78×10−4) | 2.37 (1.54×104) | .02 | |||
|
|
Week × dosage group (3 days per week) | 2.82×10−3 (5.42×10−4) | 5.21 (9.74×103) | <.001 | |||
|
|
Week × dosage group (4 days per week) | 4.73×10−3 (6.05×10−4) | 7.82 (9.29×103) | <.001 | |||
|
|
Week × dosage group (≥5 days per week) | 5.03×10−3 (6.17×10−4) | 8.14 (6.34×103) | <.001 | |||
|
|
Week × total hours | 6.01×10−6 (4.78×10−6) | 0.97 (6.50×104) | .33 | |||
aN (total observations)=111,768; N (patients)=2249; N (domains)=13.
bModel equation: domain score (weekly average) ~ week × (dosage group + total hours) + baseline domain score + age + sex + chronicity + (1+ week:patient) + (1+ week:domain).
cItalicized text indicates a significant predictor, P<.001.